RKDA

Arcadia Biosciences, Inc. (RKDA) - Q1 2026 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended March 31, 2026. Arcadia Biosciences, Inc. is a smaller reporting company focused on consumer goods, primarily through its Zola coconut water brand. The company previously held wheat-based intellectual property but has divested or terminated most related rights. The filing highlights significant liquidity challenges and a "substantial doubt" regarding the company's ability to continue as a going concern.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Product revenue decreased 8% to $1.1 million, primarily due to the absence of a $193,000 revenue reserve release recorded in Q1 2025.
• Significant Non-Operating Losses: The net loss of $4.4 million was driven by a $2.9 million loss on the January 2026 Inducement Offer (related to warrant repricing and new option issuance) and a $1.5 million unrealized loss on Above Food Ingredients, Inc. (AFII) common stock.
• Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased 32% to $1.2 million, driven by the absence of M&A fees and lower employee costs compared to the prior year.
• Asset Impairment/Default: The company recorded a full credit loss on the remaining principal of a $6.0 million promissory note from Above Food Corp., which defaulted on its first payment due in May 2025.
• Capital Structure: The company issued 683,764 shares related to the exercise of preferred investment options during the quarter.

Outlook, Risks, and Management Commentary

• Going Concern Warning: Management states that existing cash ($0.95 million) is insufficient to meet anticipated requirements for the next 12 months. The company may be forced to reduce spending, liquidate assets, or seek dissolution/bankruptcy if additional funding is not secured.
• Financing Needs: The company is seeking additional funds through debt or equity, which would result in dilution. It may also attempt to sell restricted AFII shares, though timing and proceeds are uncertain.
• Tariff Uncertainty: While a Supreme Court ruling in February 2026 invalidated certain IEEPA-based tariffs, the administration has announced new global tariffs under different statutory authorities. The impact on Zola's cost of goods sold remains uncertain.
• Legal Proceedings: The company is defending against a Proposition 65 lawsuit regarding BPA in coconut water containers. Additionally, demand letters regarding a terminated merger with Roosevelt Resources LP are considered moot but could still result in legal costs.
• Internal Controls: The company identified material weaknesses in internal controls over financial reporting, specifically regarding insufficient segregation of duties and information system controls due to reduced headcount.

Investor Verification Checklist

• Liquidity Runway: Verify the timeline and terms of any new financing arrangements to address the stated inability to fund operations for the next 12 months.
• Above Food Note Recovery: Assess the likelihood of recovering value from the defaulted $6.0 million promissory note or the restricted AFII shares held as collateral.
• Inducement Offer Impact: Review the dilution effects of the January 2026 Inducement Offer and the valuation assumptions used for the new preferred investment options.
• Tariff Exposure: Monitor the finalization of new tariff regulations and their specific impact on the cost of importing coconut water from Thailand.
• Internal Control Remediation: Evaluate the company's plan and progress in remediating the material weaknesses in financial reporting controls.